Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Wendi Qian, n/a

Cambridge University Hospitals NHS Foundation Trust, United Kingdom

Poster(s):

(497) Safety and tolerability of 2000mg intravenous sotrovimab dose in immunocompromised participants uninfected with SARS-CoV-2 in the PROTECT-V trial

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET